|
1
|
Vakiti A and Mewawalla P: Acute Myeloid
Leukemia. In: StatPearls. StatPearls Publishing, Treasure Island
(FL), 2024.
|
|
2
|
Chennamadhavuni A, Lyengar V, Mukkamalla
SKR and Shimanovsky A: Leukemia. In: StatPearls. StatPearls
Publishing, Treasure Island (FL), 2024.
|
|
3
|
Estey EH: Acute myeloid leukemia: 2019
update on risk-stratification and management. Am J Hematol.
93:1267–1291. 2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Ferrara F and Schiffer CA: Acute myeloid
leukaemia in adults. Lancet. 381:484–495. 2013.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Liu Y, Cheng Z, Pang Y, Cui L, Qian T,
Quan L, Zhao H, Shi J, Ke X and Fu L: Role of microRNAs, circRNAs
and long noncoding RNAs in acute myeloid leukemia. J Hematol Oncol.
12(51)2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Papaioannou D, Volinia S, Nicolet D,
Świerniak M, Petri A, Mrózek K, Bill M, Pepe F, Walker CJ, Walker
AE, et al: Clinical and functional significance of circular RNAs in
cytogenetically normal AML. Blood Adv. 4:239–251. 2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Mirazimi Y, Aghayan AH, Atashi A,
Mohammadi D and Rafiee M: Prognostic value of circular RNAs
expression and their correlation with clinicopathological features
in acute myeloid leukemia: A systematic review and meta-analysis.
Ann Hematol. 104:2095–2124. 2025.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Ishii H and Yano S: New therapeutic
strategies for adult acute myeloid leukemia. Cancers (Basel).
14(2806)2022.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Cingam SR and Koshy NV: Acute
Promyelocytic Leukemia. In: StatPearls. StatPearls Publishing,
Treasure Island (FL), 2024.
|
|
10
|
Li Z, Huang C, Bao C, Chen L, Lin M, Wang
X, Zhong G, Yu B, Hu W, Dai L, et al: Exon-intron circular RNAs
regulate transcription in the nucleus. Nat Struct Mol Biol.
22:256–264. 2015.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Pamudurti NR, Bartok O, Jens M,
Ashwal-Fluss R, Stottmeister C, Ruhe L, Hanan M, Wyler E,
Perez-Hernandez D, Ramberger E, et al: Translation of CircRNAs. Mol
Cell. 66:9–21.e7. 2017.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Legnini I, Di Timoteo G, Rossi F, Morlando
M, Briganti F, Sthandier O, Fatica A, Santini T, Andronache A, Wade
M, et al: Circ-ZNF609 is a circular RNA that can be translated and
functions in myogenesis. Mol Cell. 66:22–37.e9. 2017.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Hirsch S, Blätte TJ, Grasedieck S,
Cocciardi S, Rouhi A, Jongen-Lavrencic M, Paschka P, Krönke J,
Gaidzik VI, Döhner H, et al: Circular RNAs of the nucleophosmin
(NPM1) gene in acute myeloid leukemia. Haematologica.
102:2039–2047. 2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Buratin A, Paganin M, Gaffo E, Dal Molin
A, Roels J, Germano G, Siddi MT, Serafin V, De Decker M, Gachet S,
et al: Large-scale circular RNA deregulation in T-ALL: Unlocking
unique ectopic expression of molecular subtypes. Blood Adv.
4:5902–5914. 2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Huang Z, Shan R, Wen W, Li J, Zeng X and
Wan R: The emerging roles of Circ-ABCB10 in cancer. Front Cell Dev
Biol. 10(782938)2022.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Li Y, Zheng Q, Bao C, Li S, Guo W, Zhao J,
Chen D, Gu J, He X and Huang S: Circular RNA is enriched and stable
in exosomes: A promising biomarker for cancer diagnosis. Cell Res.
25:981–984. 2015.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Shao N, Xue L, Wang R, Luo K, Zhi F and
Lan Q: miR-454-3p is an exosomal biomarker and functions as a tumor
suppressor in glioma. Mol Cancer Ther. 18:459–469. 2019.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Chen P, Liu X, Zhao Y, Hu Y, Guo J and
Wang H: Global, national, and regional burden of acute myeloid
leukemia among 60-89 years-old individuals: Insights from a study
covering the period 1990 to 2019. Front Public Health.
11(1329529)2024.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Philip C, George B, Ganapule A, Korula A,
Jain P, Alex AA, Lakshmi KM, Sitaram U, Abubacker FN, Abraham A, et
al: Acute myeloid leukaemia: Challenges and real world data from
India. Br J Haematol. 170:110–117. 2015.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Nalage DN, Kudnar PS, Langhe R, Ughade B,
Sontakke T and Biradar A: Leukemia in india: Insights into
incidence, prevalence, mortality, and Disability-adjusted life
years. Cureus. 16(e62557)2024.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Kalluri R and LeBleu VS: The biology,
function, and biomedical applications of exosomes. Science.
367(eaau6977)2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Tiwari P, Shanmugam P, Karn V, Gupta S,
Mishra R, Rustagi S, Chouhan M, Verma D, Jha NK and Kumar S:
Extracellular vesicular miRNA in pancreatic cancer: From lab to
therapy. Cancers (Basel). 16(2179)2024.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Lu Y, Huang W, Li M and Zheng A:
Exosome-based carrier for RNA delivery: Progress and challenges.
Pharmaceutics. 15(598)2023.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Dou Y, Cha DJ, Franklin JL, Higginbotham
JN, Jeppesen DK, Weaver AM, Prasad N, Levy S, Coffey RJ, Patton JG
and Zhang B: Circular RNAs are down-regulated in KRAS mutant colon
cancer cells and can be transferred to exosomes. Sci Rep.
6(37982)2016.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Singh V, Uddin MH, Zonder JA, Azmi AS and
Balasubramanian SK: Circular RNAs in acute myeloid leukemia. Mol
Cancer. 20(149)2021.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Jin Y, Xing J, Xu K, Liu D and Zhuo Y:
Exosomes in the tumor microenvironment: Promoting cancer
progression. Front Immunol. 13(1025218)2022.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Li J, Li Z, Jiang P, Peng M, Zhang X, Chen
K, Liu H, Bi H, Liu X and Li X: Circular RNA IARS (circ-IARS)
secreted by pancreatic cancer cells and located within exosomes
regulates endothelial monolayer permeability to promote tumor
metastasis. J Exp Clin Cancer Res. 37(177)2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Bai H, Lei K, Huang F, Jiang Z and Zhou X:
Exo-circRNAs: A new paradigm for anticancer therapy. Mol Cancer.
18(56)2019.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Yi Q, Yue J, Liu Y, Shi H and Sun W, Feng
J and Sun W: Recent advances of exosomal circRNAs in cancer and
their potential clinical applications. J Transl Med.
21(516)2023.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Kim KM, Abdelmohsen K, Mustapic M,
Kapogiannis D and Gorospe M: RNA in extracellular vesicles. Wiley
Interdiscip Rev RNA. 8(10)2017.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Chen Y, Zhao Y, Yin Y, Jia X and Mao L:
Mechanism of cargo sorting into small extracellular vesicles.
Bioengineered. 12:8186–8201. 2021.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Qiu Y, Li P, Zhang Z and Wu M: Insights
into exosomal Non-coding RNAs sorting mechanism and clinical
application. Front Oncol. 11(664904)2021.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Fabbiano F, Corsi J, Gurrieri E, Trevisan
C, Notarangelo M and D'Agostino VG: RNA packaging into
extracellular vesicles: An orchestra of RNA-binding proteins? J
Extracell Vesicles. 10(e12043)2020.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Liu S, Wan X, Gou Y, Yang W, Xu W, Du Y,
Peng X, Wang X and Zhang X: The emerging functions and clinical
implications of circRNAs in acute myeloid leukaemia. Cancer Cell
Int. 25(167)2025.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Guo W, Gao Y, Li N, Shao F, Wang C, Wang
P, Yang Z, Li R and He J: Exosomes: New players in cancer (review).
Oncol Rep. 38:665–675. 2017.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Głuszko A, Szczepański MJ, Ludwig N, Mirza
SM and Olejarz W: Exosomes in cancer: Circulating Immune-related
biomarkers. Biomed Res Int. 2019(1628029)2019.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Zahra K, Dey T, Ashish Mishra SP and
Pandey U: Pyruvate kinase M2 and cancer: The role of PKM2 in
promoting tumorigenesis. Front Oncol. 10(159)2020.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Escrevente C, Keller S, Altevogt P and
Costa J: Interaction and uptake of exosomes by ovarian cancer
cells. BMC Cancer. 11(108)2011.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Obi P and Chen YG: The design and
synthesis of circular RNAs. Methods. 196:85–103. 2021.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Zeng Y, Zou Y, Gao G, Zheng S, Wu S, Xie X
and Tang H: The biogenesis, function and clinical significance of
circular RNAs in breast cancer. Cancer Biol Med. 19:14–29.
2022.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Zhang XO, Wang HB, Zhang Y, Lu X, Chen LL
and Yang L: Complementary sequence-mediated exon circularization.
Cell. 159:134–147. 2014.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Li L, Wei C, Xie Y, Su Y, Liu C, Qiu G,
Liu W, Liang Y, Zhao X, Huang D and Wu D: Expanded insights into
the mechanisms of RNA-binding protein regulation of circRNA
generation and function in cancer biology and therapy. Genes Dis.
12(101383)2025.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Xiong Y, Chen Y, Luo H, Shi M, Wang C, Hu
X and Zhu H: DHX9 as a prognostic biomarker and its biological
roles in acute myeloid leukemia. BMC Cancer.
25(1464)2025.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Nong T, Mehra S and Taylor J: Common
driver mutations in AML: Biological impact, clinical
considerations, and treatment strategies. Cells.
13(1392)2024.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Das A, Sinha T, Shyamal S and Panda AC:
Emerging role of circular RNA-protein interactions. Noncoding RNA.
7(48)2021.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Huang Y, Zhang C, Xiong J and Ren H:
Emerging important roles of circRNAs in human cancer and other
diseases. Genes Dis. 8:412–423. 2020.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Liu Y, Chen X, Liu J, Jin Y and Wang W:
Circular RNA circ_0004277 inhibits acute myeloid leukemia
progression through MicroRNA-134-5p/Single stranded DNA binding
protein 2. Bioengineered. 13:9662–9673. 2022.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Ping L, Jian-Jun C, Chu-Shu L, Guang-Hua L
and Ming Z: High circ_100053 predicts a poor outcome for chronic
myeloid leukemia and is involved in imatinib resistance. Oncol Res:
Feb 14, 2019 doi: 10.3727/096504018X15412701483326 (Epub ahead of
print).
|
|
49
|
Ren X, Yan H, Zhou M, Wu F, Zhang Q, Ding
Y, Li Q, Wang H, Xu C, Wang J, et al: Vincristine overcomes
cytarabine resistance in acute myeloid leukemia by suppression of
ARHGAP18-mediated cellular senescence. Blood. 144(2754)2024.
|
|
50
|
Jamal M, Song T, Chen B, Faisal M, Hong Z,
Xie T, Wu Y, Pan S, Yin Q, Shao L and Zhang Q: Recent progress on
circular RNA research in acute myeloid leukemia. Front Oncol.
9(1108)2019.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Rahmati A, Mafi A, Soleymani F, Babaei
Aghdam Z, Masihipour N, Ghezelbash B, Asemi R, Aschner M, Vakili O,
Homayoonfal M, et al: Circular RNAs: Pivotal role in the
leukemogenesis and novel indicators for the diagnosis and prognosis
of acute myeloid leukemia. Front Oncol. 13(1149187)2023.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Gu A, Jaijyan DK, Yang S, Zeng M, Pei S
and Zhu H: Functions of circular RNA in human diseases and
illnesses. Noncoding RNA. 9(38)2023.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Dong W, Bi J, Liu H, Yan D, He Q, Zhou Q,
Wang Q, Xie R, Su Y, Yang M, et al: Circular RNA ACVR2A suppresses
bladder cancer cells proliferation and metastasis through
miR-626/EYA4 axis. Mol Cancer. 18(95)2019.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Meng Q, Li S, Liu Y, Zhang S, Jin J, Zhang
Y, Guo C, Liu B and Sun Y: Circular RNA circSCAF11 accelerates the
glioma tumorigenesis through the miR-421/SP1/VEGFA axis. Mol Ther
Nucleic Acids. 17:669–677. 2019.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Ma P, Pan Y, Li W, Sun C, Liu J, Xu T and
Shu Y: Extracellular vesicles-mediated noncoding RNAs transfer in
cancer. J Hematol Oncol. 10(57)2017.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Liu J, Chen W, Zhang H, Liu T and Zhao L:
miR-214 targets the PTEN-mediated PI3K/Akt signaling pathway and
regulates cell proliferation and apoptosis in ovarian cancer. Oncol
Lett. 14:5711–5718. 2017.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Li X, Yin X, Bao H and Liu C: Circular RNA
ITCH increases sorafenib-sensitivity in hepatocellular carcinoma
via sequestering miR-20b-5p and modulating the downstream
PTEN-PI3K/Akt pathway. Mol Cell Probes. 67(101877)2023.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Pimenta DB, Varela VA, Datoguia TS,
Caraciolo VB, Lopes GH and Pereira WO: The bone marrow
microenvironment mechanisms in acute myeloid leukemia. Front Cell
Dev Biol. 9(764698)2021.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Bi J, Pu Y and Yu X: Exosomal circ_0004136
enhances the progression of pediatric acute myeloid leukemia
depending on the regulation of miR-570-3p/TSPAN3 axis. Anticancer
Drugs. 32:802–811. 2021.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Zhou Q, Xie D, Wang R, Liu L, Yu Y, Tang
X, Hu Y and Cui D: The emerging landscape of exosomal CircRNAs in
solid cancers and hematological malignancies. Biomark Res.
10(28)2022.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Wang D, Ming X, Xu J and Xiao Y:
Circ_0009910 shuttled by exosomes regulates proliferation, cell
cycle and apoptosis of acute myeloid leukemia cells by regulating
miR-5195-3p/GRB10 axis. Hematol Oncol. 39:390–400. 2021.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Du A, Yang Q, Sun X and Zhao Q: Exosomal
circRNA-001264 promotes AML immunosuppression through induction of
M2-like macrophages and PD-L1 overexpression. Int Immunopharmacol.
124(110868)2023.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Lyu T, Wang Y, Li D, Yang H, Qin B, Zhang
W, Li Z, Cheng C, Zhang B, Guo R and Song Y: Exosomes from BM-MSCs
promote acute myeloid leukemia cell proliferation, invasion and
chemoresistance via upregulation of S100A4. Exp Hematol Oncol.
10(24)2021.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Fan H, Li Y, Liu C, Liu Y, Bai J and Li W:
Circular RNA-100290 promotes cell proliferation and inhibits
apoptosis in acute myeloid leukemia cells via sponging miR-203.
Biochem Biophys Res Commun. 507:178–184. 2018.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Long F, Lin Z, Long Q, Lu Z, Zhu K, Zhao M
and Yang M: CircZBTB46 protects acute myeloid leukemia cells from
ferroptotic cell death by upregulating SCD. Cancers (Basel).
15(459)2023.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Ye D, Gong M, Deng Y, Fang S, Cao Y, Xiang
Y and Shen Z: Roles and clinical application of exosomal circRNAs
in the diagnosis and treatment of malignant tumors. J Transl Med.
20(161)2022.PubMed/NCBI View Article : Google Scholar
|
|
67
|
McKiernan J, Donovan MJ, O'Neill V,
Bentink S, Noerholm M, Belzer S, Skog J, Kattan MW, Partin A,
Andriole G, et al: A novel urine exosome gene expression assay to
predict High-grade prostate cancer at initial biopsy. JAMA Oncol.
2:882–889. 2016.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Dixon CL, Sheller-Miller S, Saade GR,
Fortunato SJ, Lai A, Palma C, Guanzon D, Salomon C and Menon R:
Amniotic fluid exosome proteomic profile exhibits unique pathways
of term and preterm labor. Endocrinology. 159:2229–2240.
2018.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Tang BJ, Sun B, Chen L, Xiao J, Huang ST
and Xu P: The landscape of exosome-derived non-coding RNA in
leukemia. Front Pharmacol. 13(912303)2022.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Das MK: Multicenter studies: Relevance,
design and implementation. Indian Pediatr. 59:571–579.
2022.PubMed/NCBI
|
|
71
|
Can C, Yang X, Jia H, Wu H, Guo X, Wei Y,
Jia Z, Liu W, Zhang A and He N: Exosomal circ_0006896 promotes AML
progression via interaction with HDAC1 and restriction of antitumor
immunity. Mol Cancer. 24(4)2025.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Li J, Zhou W, Wang H, Huang M and Deng H:
Exosomal circular RNAs in tumor microenvironment: An emphasis on
signaling pathways and clinical opportunities. MedComm (2020).
5(e70019)2024.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Xu Y, Kong S, Qin S, Shen X and Ju S:
Exosomal circRNAs: Sorting mechanisms, roles and clinical
applications in tumors. Front Cell Dev Biol.
8(581558)2020.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Wang S, Dong Y, Gong A, Kong H, Gao J, Hao
X, Liu Y, Wang Z, Fan Y, Liu C and Xu W: Exosomal circRNAs as novel
cancer biomarkers: Challenges and opportunities. Int J Biol Sci.
17:562–573. 2021.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Zhou M, Gao X, Zheng X and Luo J:
Functions and clinical significance of circular RNAs in acute
myeloid leukemia. Front Pharmacol. 13(1010579)2022.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Liu W and Cheng F: Circular RNA circCRKL
inhibits the proliferation of acute myeloid leukemia cells via the
miR-196a-5p/miR-196b-5p/p27 axis. Bioengineered.
12(7704)2021.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Motomura K, Kuwano A, Tanaka K, Koga Y,
Masumoto A and Yada M: Potential predictive biomarkers of systemic
drug therapy for hepatocellular carcinoma: Anticipated usefulness
in clinical practice. Cancers (Basel). 15(4345)2023.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Ma Y, Niu X, Yan S, Liu Y, Dong R and Li
Y: Circular RNA profiling facilitates the diagnosis and prognostic
monitoring of breast cancer: A pair-wise meta-analysis. J Clin Lab
Anal. 35(e23575)2020.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Ma J, Wen X, Xu Z, Xia P, Jin Y, Lin J and
Qian J: Predicting the influence of Circ_0059706 expression on
prognosis in patients with acute myeloid leukemia using classical
statistics and machine learning. Front Genet.
13(961142)2022.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Zheng P, Gao H, Xie X and Lu P: Plasma
exosomal hsa_circ_0015286 as a potential diagnostic and prognostic
biomarker for gastric cancer. Pathol Oncol Res.
28(1610446)2022.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Ding C, Yi X, Chen X, Wu Z, You H, Chen X,
Zhang G, Sun Y, Bu X, Wu X, et al: Warburg effect-promoted exosomal
circ_0072083 releasing up-regulates NANGO expression through
multiple pathways and enhances temozolomide resistance in glioma. J
Exp Clin Cancer Res. 40(164)2021.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Weng Q, Chen M, Li M, Zheng YF, Shao G,
Fan W, Xu XM and Ji J: Global microarray profiling identified
hsa_circ_0064428 as a potential immune-associated prognosis
biomarker for hepatocellular carcinoma. J Med Genet. 56:32–38.
2019.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Shang J, Chen WM, Liu S, Wang ZH, Wei TN,
Chen ZZ and Wu WB: CircPAN3 contributes to drug resistance in acute
myeloid leukemia through regulation of autophagy. Leuk Res.
85(106198)2019.PubMed/NCBI View Article : Google Scholar
|
|
84
|
Yan L and Yan Q: Serum circRNA_100199 is a
prognostic biomarker in acute myeloid leukemia. Int J Gen Med.
16:4661–4668. 2023.PubMed/NCBI View Article : Google Scholar
|
|
85
|
Zhang J, Zhang X, Li C, Yue L, Ding N,
Riordan T, Yang L, Li Y, Jen C, Lin S, et al: Circular RNA
profiling provides insights into their subcellular distribution and
molecular characteristics in HepG2 cells. RNA Biol. 16:220–232.
2019.PubMed/NCBI View Article : Google Scholar
|
|
86
|
Théry C, Witwer KW, Aikawa E, Alcaraz MJ,
Anderson JD, Andriantsitohaina R, Antoniou A, Arab T, Archer F,
Atkin-Smith GK, et al: Minimal information for studies of
extracellular vesicles 2018 (MISEV2018): A position statement of
the international society for extracellular vesicles and update of
the MISEV2014 guidelines. J Extracell Vesicles.
7(1535750)2018.PubMed/NCBI View Article : Google Scholar
|
|
87
|
Ghaffari K, Moradi-Hasanabad A,
Sobhani-Nasab A, Javaheri J and Ghasemi A: Application of
cell-derived exosomes in the hematological malignancies therapy.
Front Pharmacol. 14(1263834)2023.PubMed/NCBI View Article : Google Scholar
|
|
88
|
Amiri Yekta A, Dalman A, Sanati MH, Fatemi
N, Vazirinasab H, Zomorodipour A, Chehrazi M and Gourabi H:
Optimization of the electroporation conditions for transfection of
human factor IX into the goat fetal fibroblasts. Cell J.
14(270)2013.PubMed/NCBI
|
|
89
|
Pomatto MAC, Bussolati B, D'Antico S,
Ghiotto S, Tetta C, Brizzi MF and Camussi G: Improved loading of
Plasma-derived extracellular vesicles to encapsulate antitumor
miRNAs. Mol Ther Methods Clin Dev. 13:133–144. 2019.PubMed/NCBI View Article : Google Scholar
|
|
90
|
Amin AH, Sharifi LMA, Kakhharov AJ,
Opulencia MJC, Alsaikhan F, Bokov DO, Majdi HS, Jawad MA, Hammid
AT, Shalaby MN, et al: Role of acute myeloid leukemia (AML)-derived
exosomes in tumor progression and survival. Biomed Pharmacother.
150(113009)2022.PubMed/NCBI View Article : Google Scholar
|
|
91
|
Chen C, Wang J, Sun M, Li J and Wang HMD:
Toward the next-generation phyto-nanomedicines: Cell-derived
nanovesicles (CDNs) for natural product delivery. Biomed
Pharmacother. 145(112416)2022.PubMed/NCBI View Article : Google Scholar
|
|
92
|
Wang W, Wu X, Zheng J, Yin R, Li Y, Wu X,
Xu L and Jin Z: Utilizing exosomes as sparking clinical biomarkers
and therapeutic response in acute myeloid leukemia. Front Immunol.
14(1315453)2024.PubMed/NCBI View Article : Google Scholar
|
|
93
|
Chen H, Jayasinghe MK, Yeo EYM, Wu Z,
Pirisinu M, Usman WM, Pham TT, Lim KW, Tran NV, Leung AYH, et al:
CD33-targeting extracellular vesicles deliver antisense
oligonucleotides against FLT3-ITD and miR-125b for specific
treatment of acute myeloid leukaemia. Cell Prolif.
55(e13255)2022.PubMed/NCBI View Article : Google Scholar
|
|
94
|
Nehrbas J, Butler JT, Chen DW and Kurre P:
Extracellular vesicles and chemotherapy resistance in the AML
microenvironment. Front Oncol. 10(90)2020.PubMed/NCBI View Article : Google Scholar
|
|
95
|
Hong CS, Muller L, Boyiadzis M and
Whiteside TL: Isolation and characterization of CD34+ blast-derived
exosomes in acute myeloid leukemia. PLoS One.
9(e103310)2014.PubMed/NCBI View Article : Google Scholar
|
|
96
|
Percival ME, Lai C, Estey E and Hourigan
CS: Bone marrow evaluation for diagnosis and monitoring of acute
myeloid leukemia. Blood Rev. 31:185–192. 2017.PubMed/NCBI View Article : Google Scholar
|
|
97
|
Genç EE, Saraç İS, Arslan H and Eşkazan
AE: Diagnostic and treatment obstacles in acute myeloid leukemia:
Social, operational, and financial. Oncol Ther. 11:145–152.
2023.PubMed/NCBI View Article : Google Scholar
|
|
98
|
Shimony S, Stahl M and Stone RM: Acute
myeloid leukemia: 2025 update on diagnosis, Risk-stratification,
and management. Am J Hematol. 100:860–891. 2025.PubMed/NCBI View Article : Google Scholar
|
|
99
|
Floren M and Gillette JM: Acute myeloid
leukemia: Therapy resistance and a potential role for tetraspanin
membrane scaffolds. Int J Biochem Cell Biol.
137(106029)2021.PubMed/NCBI View Article : Google Scholar
|
|
100
|
Fianchi L, Quattrone M, Criscuolo M,
Bellesi S, Dragonetti G, Maraglino AME, Bonanni M, Chiusolo P, Sica
S and Pagano L: Extramedullary involvement in acute myeloid
leukemia. A single center ten years' Experience. Mediterr J Hematol
Infect Dis. 13(e2021030)2021.PubMed/NCBI View Article : Google Scholar
|
|
101
|
Döhner H, Wei AH, Appelbaum FR, Craddock
C, DiNardo CD, Dombret H, Ebert BL, Fenaux P, Godley LA, Hasserjian
RP, et al: Diagnosis and management of AML in adults: 2022
recommendations from an international expert panel on behalf of the
ELN. Blood. 140:1345–1377. 2022.PubMed/NCBI View Article : Google Scholar
|
|
102
|
Leotta S, Condorelli A, Sciortino R,
Milone GA, Bellofiore C, Garibaldi B, Schininà G, Spadaro A, Cupri
A and Milone G: Prevention and treatment of acute myeloid leukemia
relapse after hematopoietic stem cell transplantation: The state of
the art and future perspectives. J Clin Med. 11(253)2022.PubMed/NCBI View Article : Google Scholar
|
|
103
|
Li J, Wang J and Chen Z: Emerging role of
exosomes in cancer therapy: Progress and challenges. Mol Cancer.
24(13)2025.PubMed/NCBI View Article : Google Scholar
|
|
104
|
Kim MS, Haney MJ, Zhao Y, Yuan D, Deygen
I, Klyachko NL, Kabanov AV and Batrakova EV: Engineering
macrophage-derived exosomes for targeted paclitaxel delivery to
pulmonary metastases: In vitro and in vivo evaluations.
Nanomedicine. 14:195–204. 2018.PubMed/NCBI View Article : Google Scholar
|
|
105
|
Aqil F, Munagala R, Jeyabalan J, Agrawal
AK, Kyakulaga AH, Wilcher SA and Gupta RC: Milk exosomes-Natural
nanoparticles for siRNA delivery. Cancer Lett. 449:186–195.
2019.PubMed/NCBI View Article : Google Scholar
|
|
106
|
Usman WM, Pham TC, Kwok YY, Vu LT, Ma V,
Peng B, Chan YS, Wei L, Chin SM, Azad A, et al: Efficient RNA drug
delivery using red blood cell extracellular vesicles. Nat Commun.
9(2359)2018.PubMed/NCBI View Article : Google Scholar
|
|
107
|
Kamerkar S, LeBleu VS, Sugimoto H, Yang S,
Ruivo CF, Melo SA, Lee JJ and Kalluri R: Exosomes facilitate
therapeutic targeting of oncogenic kras in pancreatic cancer.
Nature. 546:498–503. 2017.PubMed/NCBI View Article : Google Scholar
|
|
108
|
Kim SM, Yang Y, Oh SJ, Hong Y, Seo M and
Jang M: Cancer-derived exosomes as a delivery platform of
CRISPR/Cas9 confer cancer cell tropism-dependent targeting. J
Control Release. 266:8–16. 2017.PubMed/NCBI View Article : Google Scholar
|
|
109
|
Qi H, Liu C, Long L, Ren Y, Zhang S, Chang
X, Qian X, Jia H, Zhao J, Sun J, et al: Blood Exosomes endowed with
magnetic and targeting properties for cancer therapy. ACS Nano.
10:3323–3333. 2016.PubMed/NCBI View Article : Google Scholar
|
|
110
|
Liu X, Zhang Y, Zhou S, Dain L, Mei L and
Zhu G: Circular RNA: An emerging frontier in RNA therapeutic
targets, RNA therapeutics, and mRNA vaccines. J Control Release.
348:84–94. 2022.PubMed/NCBI View Article : Google Scholar
|
|
111
|
Wang H, Xiao Y, Wu L and Ma D:
Comprehensive circular RNA profiling reveals the regulatory role of
the circRNA-000911/miR-449a pathway in breast carcinogenesis. Int J
Oncol. 52:743–754. 2018.PubMed/NCBI View Article : Google Scholar
|
|
112
|
Zhou Y, Zheng X, Xu B, Chen L, Wang Q,
Deng H and Jiang J: Circular RNA hsa_circ_0004015 regulates the
proliferation, invasion, and TKI drug resistance of non-small cell
lung cancer by miR-1183/PDPK1 signaling pathway. Biochem Biophys
Res Commun. 508:527–535. 2019.PubMed/NCBI View Article : Google Scholar
|
|
113
|
Zhang F, Jiang J, Qian H, Yan Y and Xu W:
Exosomal circRNA: Emerging insights into cancer progression and
clinical application potential. J Hematol Oncol.
16(67)2023.PubMed/NCBI View Article : Google Scholar
|
|
114
|
Xie R, Zhang Y, Zhang J, Li J and Zhou X:
The role of circular RNAs in Immune-related diseases. Front
Immunol. 11(545)2020.PubMed/NCBI View Article : Google Scholar
|
|
115
|
Patnaik E, Madu C and Lu Y: Epigenetic
modulators as therapeutic agents in cancer. Int J Mol Sci.
24(14964)2023.PubMed/NCBI View Article : Google Scholar
|
|
116
|
Zhang J, Gu Y and Chen B: Mechanisms of
drug resistance in acute myeloid leukemia. Onco Targets Ther.
12:1937–1945. 2019.PubMed/NCBI View Article : Google Scholar
|
|
117
|
Han B, Chao J and Yao H: Circular RNA and
its mechanisms in disease: From the bench to the clinic. Pharmacol
Ther. 187:31–44. 2018.PubMed/NCBI View Article : Google Scholar
|
|
118
|
Sun H, Xie Y, Wu X, Hu W, Chen X, Wu K,
Wang H, Zhao S, Shi Q, Wang X, et al: circRNAs as prognostic
markers in pediatric acute myeloid leukemia. Cancer Lett.
591(216880)2024.PubMed/NCBI View Article : Google Scholar
|
|
119
|
Guo S, Li B, Chen Y, Zou D, Yang S, Zhang
Y, Wu N, Sheng L, Huang H, Ouyang G and Mu Q: Hsa_circ_0012152 and
Hsa_circ_0001857 accurately discriminate acute lymphoblastic
leukemia from acute myeloid leukemia. Front Oncol.
10(1655)2020.PubMed/NCBI View Article : Google Scholar
|
|
120
|
Hu L, Zheng B, Yang Y, Chen C and Hu M:
Construction of circRNA-miRNA-mRNA network Reveal functional
circRNAs and key genes in acute myeloid leukemia. Int J Gen Med.
16:1491–1504. 2023.PubMed/NCBI View Article : Google Scholar
|
|
121
|
Li Q, Ren X, Wang Y and Xin X: CircRNA: A
rising star in leukemia. PeerJ. 11(e15577)2023.PubMed/NCBI View Article : Google Scholar
|
